Can Selenium Reduce the Susceptibility and Severity of SARS-CoV-2?-A Comprehensive Review

Int J Mol Sci. 2022 Apr 27;23(9):4809. doi: 10.3390/ijms23094809.

Abstract

The SARS-CoV-2 infection is a highly contagious viral infection, which has claimed millions of lives in the last two years. The infection can cause acute respiratory distress, myocarditis, and systemic inflammatory response in severe cases. The interaction of the viral spike protein with the angiotensin-converting enzyme in various tissues causes damage to vital organs and tissues, leading to complications in the post-infection period. Vaccines and antiviral drugs have improved patient response to the infection, but the long-term effect on vital organs is still unknown. Investigations are now focused on supportive nutrient therapies, which can mitigate the susceptibility as well as the long-term complications of COVID-19. Selenium is one such micronutrient that plays a vital role in preventing oxidative stress induced by the virus. Further, selenium is important for effective immune response, controlling systemic inflammation, and maintain overall health of humans. We examine the role of selenium in various aspects of SARS-CoV-2 infection and address the importance of selenium supplementation in reducing the susceptibility and severity of infection in this review.

Keywords: SARS-CoV-2; immunity; inflammation; micronutrient; oxidative stress; selenium.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • Humans
  • Micronutrients
  • SARS-CoV-2
  • Selenium* / therapeutic use

Substances

  • Antiviral Agents
  • Micronutrients
  • Selenium

Grants and funding

This research received no external funding.